The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancer. (2018)
Attributed to:
Accelerating translational research through Cardiff University’s Clinical Innovation pipeline
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/cbdd.13083
PubMed Identifier: 28816016
Publication URI: http://europepmc.org/abstract/MED/28816016
Type: Journal Article/Review
Volume: 91
Parent Publication: Chemical biology & drug design
Issue: 1
ISSN: 1747-0277